Revised MRPs post GST rate reduction, effective 22nd September – Making healthcare more affordable. Learn More
Company
We are driven by three core values of quality, affordability and accessibility.
R&D & Innovation
With 6 cutting-edge R&D facilities, we pioneer breakthroughs like Dydrogesterone in pharmaceutical excellence.
Safety & Sustainability
We have adopted policies aimed at complying with legislative requirements and ensuring the safety of our employees and the personnel working at our facilities or under our management.
International
Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society.
Investor Center
Mankind Pharma Ltd
NSE: MANKIND
-
-
Careers
Mankind Pharma is not just a workplace; it's a frontier of innovation. Join us in leveraging science to shape a healthier Bharat.
Shop
Discover more of Mankind
Close
Annual Report
Investor Centre

Annual Report

REVENUE
₹ 12,207 Cr
Adj. EBITDA
₹ 3,159 Cr
PAT
₹ 2,007 Cr
download FY 24-25 report
Annual Reports
FY2024-25
FY2023-24
FY2022-23
FY2021-22
FY2020-21
FY2019-20

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Financials of Subsidiaries
FY2024-25
FY2023-24
FY2022-23

Loading...

Loading...

Loading...

Know more about us
Home
About Us
R&D
Quality